CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michael W. DeGregorio

OPENALEX: A5025530600↗ORCID: 0000-0003-4349-9158↗

Affiliations

Organizations

Parker Institute for Cancer Immunotherapyauthorship · US Sunrise Medical (United States)authorship · US University of California, Davisauthorship · US

Public evidence

2 connected articles

Indeterminacy of cannabis impairment and ∆<sup>9</sup>-tetrahydrocannabinol (∆<sup>9</sup>-THC) levels in blood and breath.2022 · Europe PMC A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window.2021 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Michael W. DeGregorio - Medical Cannabis Research Engine